Vanderbilt Ingram Cancer Center

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.

A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy.

Receiving a cancer diagnosis and undergoing treatment can be an emotional experience for patients, and their families, friends and caregivers are also affected by the experience. Creative writing can provide an outlet to express and share those strong emotions.

Jeremy Warner, M.D., M.S., assistant professor of Medicine and Biomedical Informatics, has been named medical director of the Vanderbilt Cancer Registry at Vanderbilt-Ingram Cancer Center (VICC).

Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer.

Vanderbilt-Ingram Cancer Center (VICC) has unveiled a new TrueBeam linear accelerator in the Department of Radiation Oncology on the main campus to provide enhanced radiation therapy for patients.